Avax Financial Statements From 2010 to 2024
Avax Techs financial statements provide useful quarterly and yearly information to potential Avax Techs investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Avax Techs financial statements helps investors assess Avax Techs' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Avax Techs' valuation are summarized below:Avax Techs does not presently have any fundamental signals for analysis.
Check out the analysis of Avax Techs Correlation against competitors. For more information on how to buy Avax Stock please use our How to Invest in Avax Techs guide.
Check Avax Techs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avax Techs' main balance sheet or income statement drivers, such as , as well as many indicators such as . Avax financial statements analysis is a perfect complement when working with Avax Techs Valuation or Volatility modules.
Avax |
Avax Techs Company Price To Sales Analysis
Avax Techs' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Avax Techs Price To Sales | 45.03 X |
Most of Avax Techs' fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avax Techs is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Avax Techs has a Price To Sales of 45.0334 times. This is 110.44% higher than that of the Biotechnology sector and 54.24% lower than that of the Health Care industry. The price to sales for all United States stocks is notably lower than that of the firm.
Avax Techs Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Avax Techs's current stock value. Our valuation model uses many indicators to compare Avax Techs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Avax Techs competition to find correlations between indicators driving Avax Techs's intrinsic value. More Info.Avax Techs is rated third in return on asset category among its peers. It is number one stock in operating margin category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Avax Techs by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Avax Techs Financial Statements
Avax Techs shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Avax Techs investors may analyze each financial statement separately, they are all interrelated. The changes in Avax Techs' assets and liabilities, for example, are also reflected in the revenues and expenses on on Avax Techs' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
AVAX Technologies, Inc., a development stage biopharmaceutical company, develops autologous cell vaccine technologies for the treatment of cancer. AVAX Technologies, Inc. was founded in 1990 and is based in Philadelphia, Pennsylvania. Avax Techs operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 9 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Avax Stock Analysis
When running Avax Techs' price analysis, check to measure Avax Techs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avax Techs is operating at the current time. Most of Avax Techs' value examination focuses on studying past and present price action to predict the probability of Avax Techs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avax Techs' price. Additionally, you may evaluate how the addition of Avax Techs to your portfolios can decrease your overall portfolio volatility.